JP2023539736A5 - - Google Patents
Info
- Publication number
- JP2023539736A5 JP2023539736A5 JP2023513407A JP2023513407A JP2023539736A5 JP 2023539736 A5 JP2023539736 A5 JP 2023539736A5 JP 2023513407 A JP2023513407 A JP 2023513407A JP 2023513407 A JP2023513407 A JP 2023513407A JP 2023539736 A5 JP2023539736 A5 JP 2023539736A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063070209P | 2020-08-25 | 2020-08-25 | |
| US63/070,209 | 2020-08-25 | ||
| PCT/US2021/047610 WO2022046942A1 (en) | 2020-08-25 | 2021-08-25 | Method of treating an autoimmune disease with antagonistic cd40 monoclonal antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539736A JP2023539736A (ja) | 2023-09-19 |
| JP2023539736A5 true JP2023539736A5 (https=) | 2024-07-23 |
| JPWO2022046942A5 JPWO2022046942A5 (https=) | 2024-07-23 |
Family
ID=77693641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513407A Pending JP2023539736A (ja) | 2020-08-25 | 2021-08-25 | 拮抗性ｃｄ４０モノクローナル抗体で自己免疫性疾患を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230331860A1 (https=) |
| EP (1) | EP4204099A1 (https=) |
| JP (1) | JP2023539736A (https=) |
| KR (1) | KR20230054451A (https=) |
| CN (1) | CN116322761A (https=) |
| AU (1) | AU2021331087A1 (https=) |
| BR (1) | BR112023002803A2 (https=) |
| CA (1) | CA3190727A1 (https=) |
| IL (1) | IL300765A (https=) |
| MX (1) | MX2023002093A (https=) |
| WO (1) | WO2022046942A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| TWI788340B (zh) * | 2017-04-07 | 2023-01-01 | 美商必治妥美雅史谷比公司 | 抗icos促效劑抗體及其用途 |
| AU2018361743A1 (en) * | 2017-11-03 | 2020-04-09 | Novartis Ag | Anti-CD40 antibodies for use in treatment of Sjogren's syndrome |
| AR117091A1 (es) * | 2018-11-19 | 2021-07-07 | Bristol Myers Squibb Co | Anticuerpos monoclonales antagonistas contra cd40 y sus usos |
-
2021
- 2021-08-25 IL IL300765A patent/IL300765A/en unknown
- 2021-08-25 CN CN202180052235.3A patent/CN116322761A/zh active Pending
- 2021-08-25 CA CA3190727A patent/CA3190727A1/en active Pending
- 2021-08-25 KR KR1020237009804A patent/KR20230054451A/ko active Pending
- 2021-08-25 BR BR112023002803A patent/BR112023002803A2/pt unknown
- 2021-08-25 MX MX2023002093A patent/MX2023002093A/es unknown
- 2021-08-25 EP EP21766803.7A patent/EP4204099A1/en active Pending
- 2021-08-25 US US18/042,553 patent/US20230331860A1/en active Pending
- 2021-08-25 WO PCT/US2021/047610 patent/WO2022046942A1/en not_active Ceased
- 2021-08-25 AU AU2021331087A patent/AU2021331087A1/en active Pending
- 2021-08-25 JP JP2023513407A patent/JP2023539736A/ja active Pending